Showing 3 of 3 recruiting trials for “Indolent systemic mastocytosis”
RecruitingNCT07255638 ↗
A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →